Meet the Team
Bill Harriman, PhD.
SVP, Antibody Discovery
Co-Founder/CSO Crystal Bioscience
Trellis, Roche, Abgenix
UCSF-Immunology, Haas MBA
Marie-Cecile Van De Lavoir, PhD, DVM.
VP, Operations
Co-Founder and COO, Crystal Bioscience
Origen Therapeutics, Inventor germ cell technology
Fulbright Scholar, UCSF, Utrecht, Guelph, Cornell
Christel Iffland, PhD.
VP, Antibody Technology
Co-inventor of Avelumab,
EMD Serono
Dana Farber Cancer Institute, Albert Einstein College of Medicine, Univ. Nice-Sophia Antipolis
Todd Pettingill, CFA
VP, Business Development and Strategy
Ligand Pharmaceuticals
Deutsche Bank, PriceWaterhouseCoopers
UCLA Anderson MBA
Shelley Izquierdo, PhD.
Sr. Director, Antibody Discovery
GEM Technology Lead at Crystal Bioscience, Trellis
UC Berkeley
Phil Leighton, PhD. Sr. Director, Molecular Biology
Genetic Engineering Lead at Crystal Bioscience and Origen
Princeton, UCSF
Bob Chen, PhD.Sr. Director, Systems Engineering
Co-Founder and CTO, xCella Bio
Stanford Bioengineering, MIT
Ellen Collarini, PhD. Sr. Director, Cell Biology
Crystal Bioscience, Trellis, Roche
Univ. Michigan, Univ. College-London